U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968442) titled 'The Role of Obesity in Severe COVID-19 Pathophysiology' on April 28.
Brief Summary: The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths worldwide. As of 2024, the SARS-CoV-2 Omicron variant is the predominant strain circulating within the population, generally causing mild upper respiratory tract infections. However, hospitalizations and case fatalities due to COVID-19 continue (WHO 2024), and there is a high probability that a new human coronavirus will emerge in the future. Understanding the pathophysiology of severe COVID-1...